Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Birgit Geoerger

Showing results (51-60 of 179) with videos related to

Pageof 18
Sort By:
Cancers|July 20, 2019
In-Vitro and In-Vivo Establishment and Characterization of Bioluminescent Orthotopic Chemotherapy-Resistant Human Osteosarcoma Models in NSG MiceMaria Eugénia Marques da Costa, Antonin Marchais, Anne Gomez-Brouchet, et al.
Journal of Neurosurgery|July 25, 2007
Stereotactic biopsy of diffuse pontine lesions in childrenThomas Roujeau, Guilherme Machado, Matthew R Garnett, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2007
Phase II trial of irinotecan in children with relapsed or refractory rhabdomyosarcoma: a joint study of the French Society of Pediatric Oncology and the United Kingdom Children's Cancer Study GroupGilles Vassal, Dominique Couanet, Elizabeth Stockdale, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2008
Phase I study of weekly oxaliplatin in relapsed or refractory pediatric solid malignanciesBirgit Geoerger, François Doz, Jean-Claude Gentet, et al.
Cancer Research|February 7, 2002
Oncolytic activity of the E1B-55 kDa-deleted adenovirus ONYX-015 is independent of cellular p53 status in human malignant glioma xenograftsBirgit Geoerger, Jacques Grill, Paule Opolon, et al.
European Journal of Cancer (Oxford, England : 1990)|November 4, 2017
Phase II study of ipilimumab in adolescents with unresectable stage III or IV malignant melanomaBirgit Geoerger, Christophe Bergeron, Lia Gore, et al.
Plos One|November 25, 2015
Regorafenib: Antitumor Activity upon Mono and Combination Therapy in Preclinical Pediatric Malignancy ModelsEstelle Daudigeos-Dubus, Ludivine Le Dret, Claudia Lanvers-Kaminsky, et al.
Cancer Research|August 18, 2004
Oncolytic activity of p53-expressing conditionally replicative adenovirus AdDelta24-p53 against human malignant gliomaBirgit Geoerger, Gilles Vassal, Paule Opolon, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 29, 2022
Rapid and highly sensitive approach for multiplexed somatic fusion detectionSamuel Abbou, Sarah Finstuen-Magro, Brigit McDannell, et al.
Bioinformatics Advances|June 25, 2024
CellsFromSpace: a fast, accurate, and reference-free tool to deconvolve and annotate spatially distributed omics dataCorentin Thuilliez, Gaël Moquin-Beaudry, Pierre Khneisser, et al.
Pageof 18

Showing results (51-60 of 179) with videos related to

Sort By:
Pageof 18
Cancers|July 20, 2019
In-Vitro and In-Vivo Establishment and Characterization of Bioluminescent Orthotopic Chemotherapy-Resistant Human Osteosarcoma Models in NSG MiceMaria Eugénia Marques da Costa, Antonin Marchais, Anne Gomez-Brouchet, et al.
Journal of Neurosurgery|July 25, 2007
Stereotactic biopsy of diffuse pontine lesions in childrenThomas Roujeau, Guilherme Machado, Matthew R Garnett, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2007
Phase II trial of irinotecan in children with relapsed or refractory rhabdomyosarcoma: a joint study of the French Society of Pediatric Oncology and the United Kingdom Children's Cancer Study GroupGilles Vassal, Dominique Couanet, Elizabeth Stockdale, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2008
Phase I study of weekly oxaliplatin in relapsed or refractory pediatric solid malignanciesBirgit Geoerger, François Doz, Jean-Claude Gentet, et al.
Cancer Research|February 7, 2002
Oncolytic activity of the E1B-55 kDa-deleted adenovirus ONYX-015 is independent of cellular p53 status in human malignant glioma xenograftsBirgit Geoerger, Jacques Grill, Paule Opolon, et al.
European Journal of Cancer (Oxford, England : 1990)|November 4, 2017
Phase II study of ipilimumab in adolescents with unresectable stage III or IV malignant melanomaBirgit Geoerger, Christophe Bergeron, Lia Gore, et al.
Plos One|November 25, 2015
Regorafenib: Antitumor Activity upon Mono and Combination Therapy in Preclinical Pediatric Malignancy ModelsEstelle Daudigeos-Dubus, Ludivine Le Dret, Claudia Lanvers-Kaminsky, et al.
Cancer Research|August 18, 2004
Oncolytic activity of p53-expressing conditionally replicative adenovirus AdDelta24-p53 against human malignant gliomaBirgit Geoerger, Gilles Vassal, Paule Opolon, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 29, 2022
Rapid and highly sensitive approach for multiplexed somatic fusion detectionSamuel Abbou, Sarah Finstuen-Magro, Brigit McDannell, et al.
Bioinformatics Advances|June 25, 2024
CellsFromSpace: a fast, accurate, and reference-free tool to deconvolve and annotate spatially distributed omics dataCorentin Thuilliez, Gaël Moquin-Beaudry, Pierre Khneisser, et al.
Pageof 18